Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998.

Literature DB >> 10655402

Trends in antifungal susceptibility among Candida sp. Urinary isolates from 1994 and 1998.

J Baran¹, E Klauber, J Barczak, K Riederer, R Khatib.

Abstract

Antifungal susceptibilities were determined from 80 urinary isolates of Candida species collected in 1994 and 1998. Our findings demonstrate increasing geometric means of fluconazole MICs and fluconazole resistance in Candida albicans and Candida tropicalis (those for Candida glabrata were unchanged) within the 4-year span. Amphotericin B and voriconazole MICs remained constant.

Entities: Chemical Species

Mesh：

Substances：
Antifungal Agents

Year: 2000 PMID： 10655402 PMCID： PMC86229

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

10 in total

Review 1. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

Authors: M A Ghannoum; J H Rex; J N Galgiani
Journal: J Clin Microbiol Date: 1996-03 Impact factor: 5.948

2. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.

Authors: F Witthuhn; D Toubas; I Béguinot; D Aubert; C Rouger; G Remy; J M Pinon
Journal: J Clin Microbiol Date: 1999-03 Impact factor: 5.948

Review 3. Antifungal susceptibility testing: technical advances and potential clinical applications.

Authors: M A Pfaller; J H Rex; M G Rinaldi
Journal: Clin Infect Dis Date: 1997-05 Impact factor: 9.079

4. Azole drug resistance in yeasts.

Authors: E M Johnson; D W Warnock
Journal: J Antimicrob Chemother Date: 1995-11 Impact factor: 5.790

5. Clinicians' reaction to positive urine culture for Candida organisms.

Authors: O Ayeni; K M Riederer; F M Wilson; R Khatib
Journal: Mycoses Date: 1999 Impact factor: 4.377

6. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.

Authors: Y F Berrouane; L A Herwaldt; M A Pfaller
Journal: J Clin Microbiol Date: 1999-03 Impact factor: 5.948

7. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.

Authors: R Franz; S L Kelly; D C Lamb; D E Kelly; M Ruhnke; J Morschhäuser
Journal: Antimicrob Agents Chemother Date: 1998-12 Impact factor: 5.191

8. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.

Authors: A L Barry; S D Brown
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

9. Development of resistance in candida isolates from patients receiving prolonged antifungal therapy.

Authors: P Fan-Havard; D Capano; S M Smith; A Mangia; R H Eng
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191

10. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.

Authors: M A Pfaller; R N Jones; G V Doern; H S Sader; R J Hollis; S A Messer
Journal: J Clin Microbiol Date: 1998-07 Impact factor: 5.948

10 in total

5 in total

1. Survival of some medically important fungi on hospital fabrics and plastics.

Authors: A N Neely; M M Orloff
Journal: J Clin Microbiol Date: 2001-09 Impact factor: 5.948

2. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.

Authors: E Chryssanthou
Journal: J Clin Microbiol Date: 2001-11 Impact factor: 5.948